Knobbe/Martens: Intellectual Property Law

News & Resources

Catalog Search

Biopharmas Should Stay Course as High Court Mulls Patent Reviews

Friday, August 11, 2017
in

image

Partner Brent Babcock was interviewed in “Biopharmas Should Stay Course as High Court Mulls Patent Reviews,” an article published in Bloomberg BNA. 

Excerpt: The U.S. Supreme Court is set to rule in 2018 on whether a federal patent agency review procedure is constitutional, potentially upending administrative reviews of biopharma and medical technology patents. 

Read Full Article Here >>

Meet the Knobbe Martens Attorneys

Brent Babcock represents high-technology clients in every aspect of intellectual property disputes, focusing on federal district court litigation throughout the country, trials and...
Attorney Finder